Ligand validation:5O7C

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 5O7C designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5O7C_NAD_A_301	89%	64%	0.08	0.957	0.6	0.76	-	1	1	0	100%	1
6H0M_NAD_A_302	100%	66%	0.044	0.988	0.56	0.74	-	1	2	0	100%	1
5EN4_NAD_A_301	100%	65%	0.045	0.988	0.58	0.76	-	2	1	0	100%	1
5O6X_NAD_A_301	100%	66%	0.049	0.992	0.55	0.76	-	1	1	0	100%	1
5O6O_NAD_A_301	99%	65%	0.05	0.988	0.62	0.72	-	1	1	0	100%	1
6ZR6_NAD_A_302	98%	67%	0.052	0.978	0.54	0.73	-	1	1	0	100%	1
2O2Y_NAD_B_1450	100%	23%	0.024	0.995	1.79	1.4	5	3	1	0	100%	1
3CMC_NAD_O_407	100%	18%	0.022	0.996	1.63	1.92	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.